Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DRMTLGY is a medical-grade skincare company that specializes in high-performance, dermatologist-recommended products for the consumer market. The company offers a wide range of topical treatments focusing on anti-aging, sun protection, acne, and skin barrier repair. Their product line is characterized by the use of clinically proven ingredients such as peptides, niacinamide, and hyaluronic acid, formulated to be suitable for all skin types. Operating primarily through a direct-to-consumer (DTC) model, DRMTLGY has built a significant online presence and a loyal customer base by emphasizing transparency and scientific efficacy. The brand positions itself as an affordable alternative to luxury clinical skincare brands while maintaining professional-grade standards. All products are developed to be fragrance-free, paraben-free, and cruelty-free, catering to the growing demand for clean and effective dermatological solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DRMTLGY.